Cha Biotech Divests Vaccine Stake to Focus on CGT and AI

Cha Biotech cuts vaccine stake, bets on CGT, AI

Cha Biotech said Thursday it will transfer 8.95 million shares in Cha Vaccine Institute, worth 23.8 billion won ($15.8 million), to Solux, AriBio Investment Purpose No. 13 and other investors. Following the deal, Cha Biotech’s stake in the Kosdaq-listed affiliate will fall to 1.34 million shares, or 4.99 percent, marking a strategic exit from management control while retaining a minority stake for future collaboration. The proceeds will be used to strengthen core growth areas, including cell and

By The Korea Herald